首页> 外文学位 >Kinetics and mechanisms of macromolecular disposition in the rat lung.
【24h】

Kinetics and mechanisms of macromolecular disposition in the rat lung.

机译:大鼠肺中大分子沉积的动力学和机理。

获取原文
获取原文并翻译 | 示例

摘要

The kinetics and mechanisms of macromolecular absorption from the airways of the rat lung were studied in vivo and in vitro, following identical solute administration methods. The isolated perfused rat lung (IPRL) was used as an in vitro model, and the disposition of 7.4 and 4.3 kDa fluorophore-labeled polyhydroxyethylaspartamide (F-PHEA) and other small and macromolecular reference solutes was investigated across doses and in the presence of a variety of biochemical inhibitors.;Absorption profiles of F-PHEA, and the solute's lung distribution at different times after administration, were statistically identical in vivo and in vitro, showing that the IPRL possessed a viable mucociliary escalator and that macromolecular solute absorption rates from the IPRL were predictive of those in vivo. A kinetic model of the IPRL incorporating mucociliary clearance alongside active and passive absorption was developed and validated. This model was employed successfully to analyze each solute's absorption components from the rat lung following simultaneous, across-dose, nonlinear regression analysis of airway-to-perfusate absorption data. 7.4 and 4.3 kDa F-PHEA absorption from the pulmonary lung compartment occurred actively via the polyaspartamide transporter with values for Vmax,P and Km,P of 4.37/3.60 mug/min and 56.6/76.8 mug, respectively. In contrast, the magnitude of F-PHEA's passive absorption component, ka,P, was inversely related to its molecular weight, consistent with the absorption of a small proportion of each solute dose passing by restricted diffusive transport through tight junctions in the pulmonary epithelium.;The active component of 7.4 kDa F-PHEA absorption, which enhanced airway-to-perfusate transfer at low doses, was significantly inhibited in the IPRL at lowered temperature (25°C; 68.4%) and in the presence of 1.0 mM 2,4-dinitrophenol (53.3%), 100 muM ouabain (75.8%), 30.0 muM monensin (66.0%) and 30.0 muM nocodazole (68.4%). This suggested that polyaspartamide-transporter was dependent on ATP-derived energy, and probably employed an intracellular vesicular transcytotic mechanism. The airway-to-perfusate transfer of 376 Da fluorescein and 4.4 kDa fluorophore-labeled dextran had no active (dose-dependent) absorption component. However, each of these solutes showed values for solute's molecular weight-dependent passive absorption and solute-independent mucociliary clearance, when compared to those for F-PHEA.
机译:按照相同的溶质给药方法,在体内和体外研究了从大鼠肺气道吸收大分子的动力学和机理。分离的大鼠肺灌注液(IPRL)用作体外模型,研究了在不同剂量下以及在存在7.4gDa和4.3 kDa荧光团标记的聚羟乙基天冬酰胺(F-PHEA)以及其他小分子和大分子参考溶质的情况下的分布。 F-PHEA的吸收曲线和给药后不同时间的溶质在肺内的分布在体内和体外在统计学上是相同的,这表明IPRL具有可行的粘膜纤毛自动扶梯,并且从溶质中的大分子溶质吸收速率IPRL是体内那些的预测。建立并验证了IPRL的动力学模型,该模型结合了粘膜纤毛清除以及主动和被动吸收。在对气道至灌流液吸收数据进行同时,跨剂量,非线性回归分析之后,该模型已成功用于分析大鼠肺中每种溶质的吸收成分。经由聚天冬酰胺转运蛋白活跃地发生​​了来自肺肺室的7.4和4.3kDa F-PHEA吸收,Vmax,P和Km,P值分别为4.37 / 3.60马克杯/分钟和56.6 / 76.8马克杯。相反,F-PHEA的被动吸收成分的大小ka,P与分子量成反比,这与通过限制的扩散性运输通过肺上皮的紧密连接而吸收的每个溶质剂量的一小部分一致。 ;在较低的温度(25°C; 68.4%)和存在1.0 mM的条件下,IPRL显着抑制了7.4 kDa F-PHEA吸收的活性成分,在低剂量时增强了气道至灌注液的转移,2 4-二硝基苯酚(53.3%),100μM哇巴因(75.8%),30.0μM莫能菌素(66.0%)和30.0μM诺考达唑(68.4%)。这表明聚天冬酰胺-转运蛋白依赖于ATP衍生的能量,并可能利用了细胞内水泡的胞吞机制。 376 Da荧光素和4.4 kDa荧光团标记的右旋糖酐从气道到灌注液的转移没有活性(剂量依赖性)吸收成分。但是,与F-PHEA相比,这些溶质均显示出溶质的分子量依赖性被动吸收和溶质依赖性粘纤纤毛清除率的值。

著录项

  • 作者

    Sakagami, Masahiro.;

  • 作者单位

    Virginia Commonwealth University.;

  • 授予单位 Virginia Commonwealth University.;
  • 学科 Pharmaceutical sciences.
  • 学位 Ph.D.
  • 年度 2000
  • 页码 361 p.
  • 总页数 361
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号